Company Filing History:
1 out of 4,304 
1 out of 832,843 Years Active: 2021-2024
Title: Innovations of Hongyang Yao in TrkB Agonist Antibodies
Introduction
Hongyang Yao is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of TrkB agonist antibodies. With a total of 2 patents, his work focuses on innovative methods for treating conditions associated with TrkB.
Latest Patents
One of his latest patents is titled "Anti-TrkB agonist antibodies binding to D1 domain of TrkB." This invention provides an isolated TrkB agonist antibody that binds to an epitope contained in one of the extracellular domains of TrkB. It is capable of activating TrkB, wherein the extracellular domains comprise D1, D2, D3, D4, D5, and the juxtamembrane domain of TrkB. The methods described in this patent aim to treat or reduce the risk of TrkB-associated conditions, including cell differentiation, synaptic development, neural injury repair, and neurite branching.
Another significant patent is "Anti-TrkB agonist antibodies binding to D5 domain of TrkB and methods of promoting neuronal survival in motor neuron injury, stroke, or glaucoma." This invention also provides an isolated TrkB agonist antibody that binds to an epitope in the extracellular domains of TrkB. The methods outlined in this patent focus on treating or reducing the risk of conditions associated with TrkB, similar to his previous work.
Career Highlights
Hongyang Yao has worked at Tsinghua University, where he has contributed to various research projects and innovations. His academic background and research experience have played a crucial role in his development as an inventor in the biotechnology field.
Collaborations
Some of his notable coworkers include Bai Lu and Wei Guo. Their collaboration has likely contributed to the advancements in the research and development of TrkB agonist antibodies.
Conclusion
Hongyang Yao's innovative work in the field of TrkB agonist antibodies showcases his dedication to advancing biotechnology. His patents reflect significant potential for treating various neurological conditions, highlighting the importance of his contributions to the scientific community.